Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.
about
Metastatic congenital neuroblastoma associated with in situ neuroblastoma: case report and review of literature.Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.Growth, progression and chromosome instability of Neuroblastoma: a new scenario of tumorigenesis?Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project.SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settingsNeuroblastoma: the impact of biology and cooperation leading to personalized treatments.Mechanisms of neuroblastoma regressionNeuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.Characterization of neuroblastoma bone invasion/metastasis in established bone metastatic model of SY5Y and KCNR cell lines.High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathology.Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection.Spontaneous regression of neuroblastoma.Neuroblastoma: clinical and biological approach to risk stratification and treatment.Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma.
P2860
Q33738022-D91C0F51-A216-4C4E-8C2A-BA2C8803D539Q35077703-E63F0CE7-A17C-4B17-B21F-057B432E60CCQ36240957-CC0275D9-2950-40CB-B29D-A42565B2E11AQ36649728-925EF33E-56DD-4666-B680-513B9A1EFDEFQ37461968-007B3B85-B33C-4058-909D-62C133605C43Q38014527-BA8FFC8B-045B-440E-AE82-71AC673F6C01Q38261519-90977DEA-3692-40E6-B42A-2AF0841A8181Q38702196-007A06B7-684C-48C4-AFFF-E753DEF12647Q39170892-BE618C8C-9DA4-41F2-8057-A338692D592DQ44960026-98B9E191-D4E5-43F7-A7E0-3FFD89A57392Q49126642-A09EAF9E-E3F5-4543-8E56-BE07D0AC3948Q50156376-E23AE931-7DFF-47D6-9615-1D8E5BEB127AQ52639269-3BBC8F82-7513-446D-800A-28E800CD90EEQ55267254-D0DE426B-2C4A-4C72-AE03-BC903AA86FD9
P2860
Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Prognostic value of the stage ...... en birth and 18 months of age.
@ast
Prognostic value of the stage ...... en birth and 18 months of age.
@en
type
label
Prognostic value of the stage ...... en birth and 18 months of age.
@ast
Prognostic value of the stage ...... en birth and 18 months of age.
@en
prefLabel
Prognostic value of the stage ...... en birth and 18 months of age.
@ast
Prognostic value of the stage ...... en birth and 18 months of age.
@en
P2093
P2860
P356
P1476
Prognostic value of the stage ...... en birth and 18 months of age.
@en
P2093
Akira Nakagawara
Andrew D J Pearson
Bruno De Bernardi
Denah R Taggart
Katherine K Matthay
Mary Lou Schmidt
Steven G DuBois
Tom F Monclair
Wendy B London
P2860
P304
P356
10.1200/JCO.2011.35.9570
P407
P577
2011-10-03T00:00:00Z